Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
55.4M
-
Shares change
-
-190K
-
Total reported value, excl. options
-
$602M
-
Value change
-
-$3.4M
-
Put/Call ratio
-
0.55
-
Number of buys
-
74
-
Number of sells
-
-78
-
Price
-
$10.90
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q2 2022
193 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q2 2022.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.4M shares
of 58.9M outstanding shares and own 94.04% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.68M shares), VANGUARD GROUP INC (3.84M shares), STATE STREET CORP (3.72M shares), RENAISSANCE TECHNOLOGIES LLC (3.64M shares), MACQUARIE GROUP LTD (2.88M shares), Epoch Investment Partners, Inc. (2.76M shares), DIMENSIONAL FUND ADVISORS LP (2.68M shares), Assenagon Asset Management S.A. (2.53M shares), Palo Alto Investors LP (2.49M shares), and GOLDMAN SACHS GROUP INC (1.83M shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.